W. Juguet

Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial

B. Souweine, J. Timsit, B. Mégarbane, 2022, BMJ Open.

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine

N. Mongardon, P. Lim, R. Huguet, 2020, Journal of clinical medicine.

Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.

B. Souweine, J. Timsit, V. Labbé, 2023, JAMA internal medicine.

Timing of aortic valve replacement in high-gradient severe aortic stenosis: impact of left ventricular ejection fraction

F. Vincent, E. Teiger, R. Gallet, 2020, Acta cardiologica.

Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

Laurane L. Kramer, B. Souweine, M. Ziol, 2023, Annals of Intensive Care.